RxDoctor Payments DataLook up a doctor →

Tamera Pace, NP

Adult Health · Nashville, TNNPI 1427045897

Payments from drug & device makers

$16,143in general payments, 2019–2025

Across 927 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AbbVie$1K
  • Pfizer$970
  • Amgen$937
  • Lilly USA, LLC$932
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk145$2,758
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC75$1,417
AbbVie83$1,145
Pfizer60$970
Amgen(2 entities)57$937
Lilly USA, LLC67$932
Otsuka America Pharmaceutical, Inc.33$653
Novartis35$597
Kowa Pharmaceuticals America, Inc.49$573
GSK34$511
Bayer22$472
AstraZeneca26$464
Boehringer Ingelheim22$405
Astellas Pharma US Inc10$313
Merck21$309
Biohaven Pharmaceutical Holding Company Ltd.10$288
Lundbeck LLC12$286
Esperion Therapeutics, Inc.15$277
Johnson & Johnson14$241
Sumitomo Pharma America, Inc.13$235
Exact Sciences10$163
Biohaven Pharmaceuticals, Inc.8$158
Amarin Pharma, Inc.8$150
Teva Pharmaceuticals USA, Inc.5$142
Takeda Pharmaceuticals U.S.A., Inc.8$124
Xeris Pharmaceuticals, Inc.6$120
Shield Therapeutics Inc6$112
Abbott6$112
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$103
Phathom Pharmaceuticals, Inc.5$100
Eisai Inc.6$100
Sunovion Pharmaceuticals Inc.6$91
Avanir Pharmaceuticals, Inc.4$78
Alkermes, Inc.3$70
Axsome Therapeutics, Inc.2$58
Zealand Pharma US, Inc.2$49
Idorsia Pharmaceuticals US Inc3$45
Nestle Healthcare Nutrition Inc.2$42
Sanofi-aventis U.S. LLC2$38
Neurocrine Biosciences, Inc.1$38
Dexcom, Inc.2$35
Medtronic2$33
Corcept Therapeutics1$33
Nevro Corp.1$31
Impel Pharmaceuticals Inc.2$30
Biogen2$30
Vanda Pharmaceuticals Inc.2$28
Jazz Pharmaceuticals Inc.1$28
Azurity Pharmaceuticals, Inc.2$27
Medicure Pharma Inc.1$26
Mayne Pharma Commercial LLC1$24
Inspire Medical Systems, Inc.1$21
Clarus Therapeutics Inc.2$20
Phadia US Inc.1$18
Biodelivery Sciences International, Inc.1$16
IBSA Pharma Inc.1$14
Galderma Laboratories, L.p.1$14
Insulet Corporation1$13
PBG Puerto Rico LLC1$13
Vistapharm, Inc.1$13

How this compares

$16,143 in reported general payments places this provider in the 95th percentile of 352 adult health providers in Tennessee.

See all adult health providers in Tennessee →

Medicare billing

Part B allowed, 2024
$49,816
Medicare patients
106
Services billed
1,519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Nashville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →